Dr. Perlee is a seasoned executive with over 25 years in the biotech industry. She has dedicated her career to the development of innovative platforms that transform patient health. She has published over 35 peer-reviewed articles and authored multiple patents related to predicting clinical outcomes, advancing cutting edge technology platforms, and developing strategies to leverage biomarker data to inform disease prognosis. Having started her career in the fields of histocompatibility and immunogenetics, Dr. Perlee has worked with various startups, and believes the future of science lies in the hands of the next generation of scientists. This inspires her deep commitment to fostering a culture of innovation and collaboration at Regeneron.